DJIA 16,400.80 -24.05 -0.15%
NASDAQ 4,086.45 0.23 0.01%
S&P 500 1,861.88 -0.43 -0.02%
market minute promo

Roche Holding Ltd. (ADR)

NASDAQOTH: RHHBY

36.11 -0.07 (-0.18%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RHHBY $36.11 -0.18%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $36.08
Previous Close $36.17
Daily Range $35.92 - $36.19
52-Week Range $28.61 - $38.71
Market Cap $202.9B
P/E Ratio 0.00
Dividend (Yield) $0.00 (1.9%)
Volume 229,371
Average Daily Volume 1,220,002
Current FY EPS $2.07

Sector

Healthcare

Industry

Pharmaceuticals

Roche Holding Ltd. (ADR) (RHHBY) Description

Website:

News & Commentary Rss Feed

Novartis Vs. Everyone: Biologic Knockoffs

5 Pharmas Spending the Most to Develop Drugs: Merck, AstraZeneca, Roche, Bristol, and Lilly

Eli Lilly, Bristol-Myers Squibb, Roche, AstraZeneca, and Merck top the charts.

A Big Pharma Titan Prepares For the Next Generation

Roche looks to maintain leadership into a new generation of oncology.

Is Gilead About to Become an Oncology Powerhouse?

Gilead's (GILD) expanding oncology pipeline could give investors some exciting opportunities.

2 Health Care Partnerships Go Head-To-Head

While the partnership between GlaxoSmithKline (NYSE: GSK) and Ligand (NASDAQ: LGND) seems to be moving forward, the partnership between Roche (OTCMKTS: RHHBY) and PDL (NASDAQ: PDLI) has seemingly reached its end

AstraZeneca’s Alzheimer’s Drug Advances: Now What?

AstraZeneca reported disappointing fourth quarter revenues but showed progress with an Alzheimer's therapy the company has under development.

2 Deaths, 25% Plunge -- And Still A Big Upside

3 Ways Ariad Pharmaceuticals Can Salvage Iclusig

Iclusig has taken quite a few knocks since October, but there are three ways Ariad could rebuild the brand's value and boost shareholder value in the process.

Merck & Co., Inc. Shows Us How to Post Losses and Still Beat the Market

Here’s how to post a 28.6% profit loss, miss estimates, and still beat the S&P 500.

3 Stocks Poised to Dominate the Market in 2014

These companies could have a great 2014. Here's why.

See More RHHBY News...

RHHBY's Top Competitors

RHHBY $36.11 (-0.18%)
Current stock: RHHBY
JNJ $99.13 (0.38%)
Current stock: JNJ
NVS $84.53 (0.14%)
Current stock: NVS
GSK $52.57 (-0.47%)
Current stock: GSK